Disparate Molecular Properties of Two Hypertrophic Cardiomyopathy-Associated cMyBP-C Mutants Reveal Distinct Pathogenic Mechanisms Beyond Haploinsufficiency. This evidence concerns the gene MYBPC3 and hypertrophic cardiomyopathy.